Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
6-K
M&A activity
confidence 95%
filed 2026-08-12
The Company entered into a share purchase agreement on August 11, 2026, to acquire 19% of Jurong Day & Night Clinic Pte. Ltd. for US$256,500 in consideration shares. This constitutes a material acquisition under Item 1.01 of Form 8-K (or equivalent 6-K disclosure). The transaction involves equity issuance (186,410 restricted shares), regulatory approvals, and integration obligations, all hallmarks of M&A activity that would affect a reasonable investor's assessment of the registrant's capital structure and strategic direction.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-08-12
The filing discloses a comprehensive operational update on Nova Minerals' 2026 field season activities at its Estelle Gold and Critical Minerals Project in Alaska. The press release details multiple concurrent operational milestones: three diamond drill rigs operating 24/7, bulk sampling and drilling at multiple prospects (Styx, RPM, Stibium, Train), successful laboratory-scale production of military-grade antimony trisulfide, permitting progress, infrastructure development, and equipment delivery for a planned antimony pilot plant. While this is clearly an operational/strategic disclosure about project development progress rather than a specific named event type (not M&A, not a material impairment, not a workforce action), the convergence of multiple workstreams toward near-term antimony production and the company's positioning in the U.S. critical minerals strategy would be material to a reasonable investor assessing the registrant's development trajectory and execution capability.
View raw filing on EDGAR →
6-K
M&A activity
confidence 95%
filed 2026-08-12
EX-99.1
Ming Shing announced entry into a stock purchase agreement to acquire the entire issued share capital of Meals Through Seasons Limited for US$510 million in securities (150 million Class A ordinary shares at US$1.00 per share plus US$360 million in unsecured convertible promissory notes). This is a material acquisition transaction that would significantly affect the registrant's financial condition and shareholder base through substantial dilution.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-08-12
EX-99.1
This press release announces completion of Front-End Engineering Design (FEED) and Factory Acceptance Tests (FAT) on two green hydrogen projects by BrightHy Solutions, a wholly-owned subsidiary. These are material operational milestones demonstrating project execution progress on hydrogen infrastructure—a core business line for Fusion Fuel. While not a discrete M&A event, earnings release, or executive change, the announcement of significant project advancement on previously announced initiatives represents material operational progress that would affect a reasonable investor's assessment of the company's ability to execute its hydrogen business strategy.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-08-12
The filing discloses entry into a Strategic Share Issuance Agreement under which Fusemachines will issue up to 1,250,000 shares of common stock to Qintess in three tranches, contingent on Qintess achieving minimum service spend thresholds under a Master License and Services Agreement. Item 3.02 explicitly classifies this as an unregistered sale of equity securities under Section 4(a)(2) and Regulation D. While the agreement also involves a material commercial relationship with $6.5 million in committed services spend, the primary 8-K disclosure mechanism and the explicit Item 3.02 filing indicate the equity issuance is the material event being reported.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-08-12
ENvue Medical entered into a Common Shares Purchase Agreement on August 12, 2026, establishing a committed equity facility of up to $50 million whereby the Company can sell common stock to an institutional investor at 90% of the three-day volume-weighted average price. This is a classic at-the-market (ATM) or committed equity offering structure that allows the Company to raise capital through dilutive equity issuance at its discretion. The filing also discloses a Second Amendment to a prior Series H Preferred Stock purchase agreement increasing additional investment rights to $59 million. Both transactions represent material dilutive equity issuances typical of small- and mid-cap companies raising capital.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 75%
filed 2026-08-12
The filing discloses that CEO Nicholas Liuzza invested $500,000 in the Company through a convertible note approved by the Board of Directors. The note will automatically convert into common stock at a specified price on August 19, 2026. This represents the creation of a new direct financial obligation (a convertible debt instrument) by the registrant, which is the hallmark of debt_issuance. While the instrument is convertible equity-like in nature, the primary event disclosed is the issuance of the convertible note itself, a debt security.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-12
The filing discloses Dyadic's second-quarter 2026 financial results via a press release dated August 12, 2026, filed under Item 2.02 (Results of Operations and Financial Condition). The press release includes consolidated statements of operations and balance sheets, reporting Q2 2026 revenue of $961,138, net loss of $2,123,884 ($(0.06) per share), and cash position of $4.8 million as of June 30, 2026. This is a standard quarterly earnings disclosure material to investors assessing the company's financial performance and operational progress.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 85%
filed 2026-08-12
The filing's primary disclosure is the results of an Extraordinary General Meeting held on August 11, 2026, where shareholders voted on two proposals: the Extension Amendment Proposal (to extend the business combination deadline by 12 months) and the Trust Agreement Amendment Proposal. Item 5.07 explicitly reports the voting results, with both proposals receiving unanimous approval (2,221,965 FOR votes, 0 AGAINST, 0 ABSTAIN). While the filing also includes Item 1.01 (material definitive agreement) and Item 5.03 (articles amendment), the central event is the shareholder vote and its results, which is material to investors in a SPAC context as it directly affects the company's timeline to complete a business combination.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-08-12
EX-99.1
This is a press release announcing Almonty's second quarter 2026 financial results, including revenue of $43.0 million (498% YoY increase), net income of $181.8 million, and Adjusted EBITDA of $17.6 million. The document presents a comprehensive financial summary table, detailed commentary on operational performance, and cash flow metrics for the three and six months ended June 30, 2026. This is a classic earnings release disclosing quarterly financial results.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-08-12
The filing discloses a completed private placement of 1,373,152 shares of common stock at $3.00 per share for $4.12 million in gross proceeds, sold to accredited investors and non-U.S. persons under Section 4(a)(2), Rule 506(b), and Regulation S exemptions. Items 1.01 and 3.02 explicitly address the unregistered sale of equity securities, which is the defining characteristic of a dilutive issuance. The shares are restricted and the company committed to file a resale registration statement within 90 days.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-08-12
Item 7.01
XCF Global announced initial commercial sales of renewable diesel to Tartan Oil LLC (a Berkshire Hathaway subsidiary), with estimated monthly revenue of $12.86–$13.86 million. This represents a material operational milestone—the company's transition from production to revenue-generating commercial operations at its New Rise Renewables Reno facility. While the disclosure is operational in nature (a significant commercial contract and customer relationship), it does not fit the specific categories of M&A activity, debt issuance, or other named financial events; it is best classified as a material operational/strategic business event.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-12
The 8-K discloses financial results for the fiscal quarter and six months ended June 30, 2026 under Item 2.02 (Results of Operations and Financial Condition). The press release (Exhibit 99.1) provides detailed quarterly and six-month financial highlights, including revenue, gross profit, net loss, and Adjusted EBITDA metrics, along with management commentary and forward-looking guidance. This is a standard earnings release disclosure material to investors assessing the company's operational and financial performance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-12
The 8-K discloses CVD Equipment's second quarter 2026 financial results via a press release dated August 12, 2026, filed under Item 2.02 (Results of Operations and Financial Condition). The press release includes condensed consolidated statements of operations and balance sheets, reporting Q2 2026 net income of $12.6 million (driven by a $13.9 million gain on the SDC divestiture), net loss from continuing operations of $1.4 million, and key operational metrics. This is a standard earnings release disclosure material to investors assessing the registrant's financial performance.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-08-12
EX-99.1
This exhibit is a press release announcing unaudited financial and operating results for the three months ended June 30, 2026 (Q1 FY2027). It discloses revenue of INR 1,879.0 million (down 10.4% YoY), Adjusted EBITDA of INR 215.9 million (up 4.7% YoY), and profit of INR 40.9 million (down 62.8% YoY), along with detailed segment performance and management commentary. This is a discrete earnings announcement, not a periodic financial report filing itself.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-12
The 8-K discloses Omega Flex's financial results for the six months and three months ended June 30, 2026 via a press release attached as Exhibit 99.1. Item 2.02 explicitly states the Company "issued a press release reporting its results for the six months and three months ended June 30, 2026." The press release presents net sales, net income, and earnings per share comparisons to prior-year periods, which is the core content of an earnings release. While the filing also mentions CE Mark approval for MediTrac® corrugated medical tubing, the primary disclosure vehicle and Item classification is the earnings announcement.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-12
The 8-K discloses GameSquare's financial results for Q2 and six months ended June 30, 2026 via Item 2.02 (Results of Operations and Financial Condition). The press release highlights material operational metrics: revenue up 137% YoY to $18.5M, gross margin expansion to 49.0%, and adjusted EBITDA turning positive at $1.0M. This is a standard earnings release disclosure with forward guidance for FY2026 ($85-90M revenue, $5M+ adjusted EBITDA), making it material to investors assessing the company's financial trajectory.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-12
The 8-K discloses Nortech Systems' second quarter 2026 financial results under Item 2.02 (Results of Operations and Financial Condition). The filing includes a news release dated August 12, 2026, titled "Nortech Systems Reports Second Quarter Results," with detailed consolidated financial statements, comparative metrics (Q2 2026 vs. Q2 2025), and management commentary on revenue growth, margins, and backlog. This is a standard quarterly earnings disclosure material to investors assessing the company's operational and financial performance.
View raw filing on EDGAR →
8-K
M&A activity
confidence 85%
filed 2026-08-12
The filing discloses Amendment No. 2 to an Asset Purchase Agreement with Titan Crest, LLC, which materially modifies the terms of a prior acquisition of 5G ORAN radio technology assets. The amendment reduces the aggregate purchase price from $8,000,000 to $7,000,000 and restructures payment terms, reflecting substantial performance issues by the seller. This constitutes a material modification to an existing material acquisition agreement under Item 1.01.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-08-12
The filing discloses Earth Science Tech's acquisition of Meduvo LLC, a California compounding pharmacy, announced on August 12, 2026. Item 8.01 explicitly states the Company "entered into an agreement to acquire Meduvo LLC" on August 11, 2026. The press release (Exhibit 99.1) describes this as a "strategic acquisition" that "serves as an immediate growth catalyst" and expands ETST's operational footprint to 34 U.S. jurisdictions. Although the 8-K notes the transaction amount is "immaterial," the acquisition itself is material to investors as it represents a significant strategic expansion of the Company's compounding pharmacy operations and geographic reach.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-12
The 8-K discloses quarterly financial results for Q2 2026 via a press release filed under Item 8.01. The press release reports royalty income of $1,109,661 in Q2 2026, cash operating expenses, capital investments, equity raises, and debt reduction—all core financial metrics. This is a standard earnings release disclosure, material to investors assessing the company's operational and financial performance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-12
Item 2.02
The filing discloses SKYX's Q2 2026 financial results via an earnings press release dated August 12, 2026, attached as Exhibit 99.1. The press release reports record Q2 revenues of $25.3 million (14% growth QoQ, 10% YoY), gross profit of $7.3 million, net loss of $8.2 million, and cash position of $27.7 million. This is a standard quarterly earnings disclosure material to investors assessing the company's financial performance and trajectory.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-08-12
EX-99.1
RedCloud announced two non-binding Memoranda of Understanding to deploy its RAID and CORE engines with Dheer Marketing India and Klakshya Marketing, targeting 11 apparel brands, 25,000+ SKUs, and 1,250+ buyer points across India. This is a material operational and strategic milestone—a significant commercial deployment announcement in a major market—but does not fit the specific event categories (not M&A, not a discrete financial event, not a governance change). The MOUs are explicitly non-binding and definitive agreements are targeted for Q4 2026, making this an operational partnership/deployment announcement rather than a binding transaction.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-12
The 8-K discloses Interpace Biosciences' Q2 2026 financial results under Item 2.02 (Results of Operations and Financial Condition), with a press release announcing revenue of $9.1 million, income from continuing operations of $0.3 million, and key operational metrics including 9% year-over-year thyroid revenue growth. The filing includes condensed consolidated statements of operations and selected balance sheet and cash flow data, which are typical of an earnings release disclosure.
View raw filing on EDGAR →
6-K
Exec departure
confidence 95%
filed 2026-08-12
The 6-K discloses two separate board member resignations: Mr. Yu-yun Tristan Kuo resigned effective August 5, 2026, and Mr. Chun Pong (Colman) Chiu resigned effective August 12, 2026, both from their Board positions and all committee assignments. Both resignations are explicitly stated to be unrelated to disagreements with the Company. These are material executive departures that would affect a reasonable investor's assessment of the Company's governance and leadership structure.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-12
The 8-K discloses Datacentrex's financial results for Q2 2026 (quarter ended June 30, 2026) under Item 2.02 Results of Operations and Financial Condition. The press release (Exhibit 99.1) reports quarterly revenue of $1.9 million, a GAAP net loss of $5.5 million, and key operational metrics including cash position of $51.9 million and no debt. This is a standard quarterly earnings announcement material to investors assessing the company's financial performance and operational status.
View raw filing on EDGAR →
8-K
Governance Other
confidence 85%
filed 2026-08-12
The filing discloses a 1-for-8 reverse stock split of My Size's common stock, approved by stockholders on July 21, 2026 and effective August 12, 2026. The company explicitly states the reverse split was undertaken "to regain compliance with the continued listing requirements of Nasdaq and make the common stock more attractive to certain institutional investors." This is a governance/capital structure event that materially affects security holders' rights and the company's listing status, though it does not fit the specific categories of exec_departure, exec_appointment, exec_compensation, or shareholder_vote_results (the vote already occurred and is being reported as implemented).
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-12
The 8-K discloses financial results for Q2 and first half 2026 under Item 2.02, with a press release attached as Exhibit 99.1. The filing reports GAAP net loss of $10.9 million for Q2 2026 and $21.1 million for the first half, along with adjusted net loss figures, cash position, and business milestones including EPA certification and production vehicle orders. This is a standard quarterly earnings release material to investors assessing the company's financial performance and operational progress.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-08-12
XMax Inc. entered into a Securities Purchase Agreement on August 10, 2026, to acquire 561,426 ordinary shares of Aerora Technology Co., Ltd. for approximately $12 million (Item 1.01 and Item 2.01). This represents a material acquisition of equity interests in another company, disclosed under the standard M&A Items 1.01 and 2.01, and would materially affect a reasonable investor's assessment of the registrant's capital deployment and strategic direction.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-12
The 8-K discloses quarterly financial results for the three months ended June 30, 2026, with net income of $501,065 ($0.24 per diluted share), representing a 107% increase year-over-year. Item 2.02 explicitly states the registrant "issued a news release to announce its financial results," and the attached Exhibit 99.1 is a press release reporting Q1 FY2027 earnings with revenue, net income, and per-share metrics. This is a standard earnings release disclosure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-08-12
The filing discloses results of a special meeting of stockholders held on August 11, 2026, under Item 5.07. Two proposals were voted upon: (1) approval of a 5,000-for-1 reverse stock split of common stock, which passed with 9,610,239,283 votes for and 852,596,155 against, and (2) approval of adjournment authority, which also passed. A reverse stock split is a material capital structure event affecting all shareholders and is typically material to investors assessing the registrant's financial condition and equity structure.
View raw filing on EDGAR →
8-K
Covenant Breach
confidence 92%
filed 2026-08-12
Item 2.04 discloses a "Floor Price Trigger" under Pre-Paid Purchase agreements with Streeterville Capital, triggered when the company's stock VWAP fell below $0.25 per share for five trading days within seven consecutive days. This triggering event accelerates a direct financial obligation: mandatory monthly cash repayments of $962,500 beginning August 9, 2026, continuing until the outstanding balance is paid in full. This is a classic covenant breach scenario—a technical default that accelerates financial obligations and signals potential financial distress.
View raw filing on EDGAR →
8-K
Auditor Change
confidence 98%
filed 2026-08-12
Item 4.01
This is a straightforward auditor change disclosed under Item 4.01. The registrant dismissed BDO USA, P.C. effective August 10, 2026, and simultaneously engaged Schneider Downs & Co., Inc. as its new independent registered public accounting firm. The filing confirms no disagreements or reportable events with the prior auditor, indicating a routine transition rather than a conflict-driven change. Auditor changes are material events affecting investor assessment of financial reporting reliability.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 95%
filed 2026-08-12
Core AI Holdings entered into a Market Issuance Sales Agreement on August 11, 2026, to sell up to $3,539,021 of common shares through an at-the-market (ATM) offering program. This is a dilutive equity issuance under an effective shelf registration statement (Form F-3), which would materially affect existing shareholders through dilution and is a material capital-raising event.
View raw filing on EDGAR →
6-K
Governance Other
confidence 85%
filed 2026-08-12
EX-99.1
This exhibit is a notice and proxy statement for an extraordinary general meeting of shareholders scheduled for August 31, 2026. The meeting addresses six proposals: (1) a massive increase in authorized share capital from US$100,000 to US$10,000,000,000; (2) a 15-for-1 share consolidation; (3) adoption of amended and restated memorandum and articles of association including conversion rights and dispute-resolution provisions; (4) issuance of 2.9 million Class B shares to Hong Loon Gan; (5) general authorization for directors to implement the foregoing; and (6) adjournment if needed. While the document contains multiple governance and capital-structure elements, it is fundamentally a shareholder-meeting notice and proxy solicitation—a governance event. The share consolidation and capital increase are material structural changes, and the issuance to a named individual is a dilutive event, but the primary disclosure is the meeting notice itself, which falls under governance_other rather than a specific event type like dilutive_issuance or exec_compensation.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-12
Item 2.02
MariMed Inc. issued a press release on August 12, 2026 announcing its financial results for the three- and six-month periods ended June 30, 2026. The disclosure includes consolidated financial highlights showing revenue of $41.9M and $81.4M for Q2 and H1 2026 respectively, along with detailed operational metrics, management commentary, and condensed consolidated financial statements. This is a standard quarterly earnings release disclosure under Item 2.02.
View raw filing on EDGAR →
8-K
Earnings release
confidence 97%
filed 2026-08-12
Item 2.02
Tecogen Inc. issued a press release disclosing quarterly and six-month financial results for the period ended June 30, 2026, reporting revenues of $5.75 million (down 21.2% year-over-year) and a net loss of $2.15 million (compared to $1.46 million loss in Q2 2025), with management commentary and supplemental information provided in connection with an earnings conference call scheduled for August 13, 2026.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 85%
filed 2026-08-12
Item 8.01
News Corporation disclosed daily buy-back notifications under its US$1 billion repurchase program authorized July 15, 2025, with approximately US$420.6 million already deployed. The Item 8.01 disclosure covers ongoing share repurchases for Class A and Class B common stock executed through Goldman Sachs, with specific daily transaction details (10.7 million Class A shares and 62,323 Class B shares purchased on August 12, 2026 for approximately US$274.3 million combined). Share repurchases constitute a return of capital to shareholders and fall within the dividend_distribution taxonomy as a capital allocation mechanism.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-12
Item 2.02
This is a clear earnings release for the fourth quarter and full fiscal year ended June 30, 2026. The Item 2.02 disclosure explicitly states "the Company issued an earnings release for the fourth quarter ended June 30, 2026" with the earnings release attached as Exhibit 99.1. The exhibit contains comprehensive financial results including net sales ($371.6M for Q4, $1,431.4M for FY2026), operating income, net income, EPS, and forward guidance for fiscal 2027, all typical of a quarterly/annual earnings announcement.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-12
Item 2.02
American Strategic Investment Co. announced second quarter 2026 financial results, reporting revenue of $7.3M, net loss of $8.3M, and adjusted EBITDA of $2.4M for the quarter ended June 30, 2026.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-12
Item 2.02
National Vision issued a press release on August 12, 2026 announcing financial results for the quarter ended July 4, 2026, disclosing net revenue of $498.8 million (up 2.5%), net income of $12.4 million, and Adjusted Diluted EPS of $0.25. The company also raised its full-year Adjusted Operating Income guidance and tightened its Adjusted Comparable Store Sales Growth outlook. This is a standard quarterly earnings release furnished under Item 2.02 of Form 8-K.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-12
Item 2.02
BETA Technologies issued a press release on August 12, 2026 announcing its financial and operating results for the quarter ended June 30, 2026, including Q2 revenues of $14.7 million, net loss of ($148.8) million, and updated full-year 2026 guidance. The filing explicitly states this disclosure is "intended to be furnished under Item 2.02 of Form 8-K, 'Results of Operations and Financial Condition'" with the full press release attached as Exhibit 99.1, which is the standard format for quarterly earnings releases.
View raw filing on EDGAR →
6-K
Earnings release
confidence 98%
filed 2026-08-12
EX-99.1
This is a press release announcing Riskified's Q2 2026 financial results for the three and six months ended June 30, 2026. The exhibit discloses revenue of $98.7 million (22% YoY growth), net loss of $(9.1) million for Q2, Adjusted EBITDA of $3.9 million, and raised full-year 2026 guidance for both revenue ($400–$410 million) and Adjusted EBITDA ($33–$39 million). The company also reports strong operational metrics including new merchant acquisition, competitive win rates above 75%, and continued share repurchases. This is a discrete earnings announcement, not a periodic financial report, and the results and guidance raise are material to investors.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-12
Item 2.02
This is a clear earnings release for Q2 2026 (quarter ended June 30, 2026) issued on August 12, 2026. The press release discloses quarterly financial results including total revenue of $398 million, ARR of $1,143 million, operating loss of $(2,070) million, net loss of $(1,971) million, and EPS of $(7.34), along with forward guidance for Q3 and full year 2026. The filing includes condensed consolidated financial statements and is a standard Item 2.02 earnings disclosure material to investors assessing the company's financial performance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 94%
filed 2026-08-12
Item 2.02
Acumen Pharmaceuticals disclosed Q2 2026 financial results via press release furnished under Item 2.02, reporting a net loss of $32.7 million, R&D expenses of $27.8 million, and a cash balance of $110.2 million as of June 30, 2026, along with clinical trial progress updates on ALTITUDE-AD and the EBD program.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-12
Item 2.02
Fervo Energy issued a press release on August 12, 2026 announcing Q2 2026 financial results, including an operating loss of $28.7 million and net loss of $55.9 million, along with operational highlights including Cape Station Phase I progress and capital expenditure guidance.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 95%
filed 2026-08-12
Item 8.01
The press release discloses a pending Nasdaq delisting hearing scheduled for August 20, 2026, with the Company's stock currently trading under a stayed delisting action. The disclosure explicitly states "The Company's timely hearing request has stayed the delisting action" and notes that the Panel may determine to delist the Company's securities. This is a material disclosure of delisting risk under Item 3.01 taxonomy, as it directly addresses the registrant's continued listing status and the threat of delisting pending a regulatory hearing.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-12
Item 2.02
Applied Aerospace & Defense issued a press release on August 12, 2026, announcing its second quarter 2026 financial results, including revenue of $167.3 million (up 47.4% YoY), a net loss of $154.0 million (primarily due to IPO-related expenses), and Adjusted EBITDA of $36.4 million. The full press release is furnished as Exhibit 99.1, which is the standard format for earnings disclosures under Item 2.02. This is a material quarterly earnings announcement for a newly public company.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-12
Item 2.02
Local Bounti issued a press release on August 12, 2026 announcing its financial results for the quarter ended June 30, 2026, disclosing key metrics including 14% revenue growth to $13.9 million, improved net loss to $19.8 million, and 17% improvement in adjusted EBITDA loss to $5.8 million. The press release is furnished as Exhibit 99.1 and constitutes a standard quarterly earnings disclosure under Item 2.02.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-12
Item 2.02
Madison Square Garden Entertainment Corp. announced its financial results for the fourth quarter and fiscal year ended June 30, 2026 via press release (Exhibit 99.1). The disclosure reports full-year revenues of $1.1 billion (up 13% YoY), operating income of $141.5 million (up 16%), and adjusted operating income of $262.2 million (up 18%), along with detailed quarterly and segment results. This is a standard earnings release disclosure under Item 2.02.
View raw filing on EDGAR →